rhodopsin mutations result in autosomal dominant retinitis pigmentosa (ADRP ), the most frequent being Proline-23 substitution by histidine (Rho P23H ). Although cellular and rodent animal models have been developed, the pathogenic mechanisms leading to Rho P23H -induced cell death are still poorly understood. For this, we have used a Drosophila model by introducing a mutation in the fly rhodopsin-1 gene (Rh1 P37H ) that corresponds to human Rho
INTRODUCTION
Retinitis pigmentosa (RP) represents a group of inherited disorders causing photoreceptor degeneration. Even though RPs are heterogeneous for disease severity and affected gene, they are all characterized by progressive blindness that is at present neither preventable nor curable (1) . Twenty-five percent of autosomal dominant retinitis pigmentosa (ADRP) is linked to more than 100 different mutations scattered throughout the rhodopsin gene and affect different processes (http://www.sph.uth.tmc.edu/Retnet/) (2) .
Proline substitution at position-23 by histidine (P23H) is the most frequent rhodopsin mutation causing ADRP (3) . Moreover, Proline-23 by leucine (P23L) or by alanine (P23A) substitutions are also associated with ADRP (4, 5) .
Although transgenic mice and rats expressing Rho P23H recapitulate dominant photoreceptor degeneration, the pathogenic mechanism is still under debate (6, 7) , for most of the other photoreceptor degenerative models (8) . Moreover, controversial data on the subcellular localization of the mutant protein make it difficult to clarify the molecular bases of the Rho P23H -induced degenerative phenotype. Drosophila has been successfully used to study human pathologies (9) . Moreover, despite a different overall organization, fly and vertebrate retina share structural and molecular features: photoreceptor cells display similar structures sensitive to light, as Drosophila rhabdomeres are functionally equivalent to vertebrate photoreceptor outer-segments. Moreover, light stimuli are transduced by pathways that display many common key players (10, 11) .
We have developed a transgenic approach to study Rho P23H -induced RP and shown that flies harboring a mutated Rhodopsin-1, Rh1
P37H , analogous to human Rho P23H , develop dominant photoreceptor degeneration linked to progressive loss of vision. This age-and light-dependent phenotype recapitulates the phenotypes observed in Rho P23H patients and rodents. We show that mutant Rhodopsin is partially active and that it interferes with the phototransduction pathway. Although part of the Rh1 P37H protein is properly transported to photoreceptor rhabdomeres, most of it is trapped in rough endoplasmic reticulum (ER), triggering activation of stress-specific p38 and JNK mitogen-activated protein kinases (MAPKs). Finally, the degeneration phenotype is rescued by p35 anti-apoptotic factor.
In conclusion, our fly model constitutes a promising genetic tool to uncover the molecular mechanisms underlying retinal degeneration and to identify potential therapeutic pathways.
RESULTS

Rh1
P37H induces dominant light-and age-dependent retinal degeneration in flies Drosophila compound eye is comprised 800 ommatidia, each harboring eight photoreceptors (R1 -R8). Photoreceptor rhabdomeres are specialized portions of plasma membrane comprised thousands of microvilli corresponding to vertebrate photoreceptor outer-segments and containing phototransduction proteins.
Rhodopsin-1 (Rh1), which is expressed in outer photoreceptors (R1 -R6), represents the major fly Rhodopsin and displays 22% amino acid identity with human Rhodopsin (12, 13) . Amino acid alignment of opsins throughout phyla highlights both conservation of Proline-23 in vertebrates and its correspondence with Proline-37 in Drosophila (http:// www.gpcr.org/7tm/seq/001_004/001_004.MSF.mview2.html and Supplementary Material, Fig. S1 ). This residue lies in the N-terminal, extracellular part of the protein, a region of unknown function.
To develop a fly model for Rhodopsin P23H (Rho P23H )-induced RP, we substituted Proline-37 by histidine and produced transgenic flies that, in addition to endogenous Rh1, express either Rh1 P37H or wild-type Rh1 (Rh1 WT ) under the control of the rh1 promoter (14) (referred to as lines Rh1 P37H and Rh1 WT throughout the text). Rho P23H patients and rodents present no vision deficit at birth (3, 7, 15, 16) . To determine whether Rh1 P37H causes agedependent retinal degeneration in flies, we investigated photoreceptor morphology as a function of age. Rhabdomeres of wild-type and transgenic (Rh1 WT and Rh1 P37H ) flies raised under day/night light conditions show no sign of photoreceptor degeneration at eclosion (Fig. 1A, C and E) . Rh1 P37H flies, however, display vacuoles in R1-R6 cytoplasm (data not shown) and slightly mislocalized (in 80% of the samples) (Fig. 1C) . This very first degeneration signs are due to light exposure during pupal life, because pupae of the same genotype kept in the dark show no cytoplasm defect (data not shown).
Large number of R1 -R6 photoreceptors degenerate by day 21 post-eclosion (Fig. 1D ) and inner photoreceptors (R7 and R8) remaining intact (white arrow heads in Fig. 1D ); in contrast, wild-type flies show no sign of degeneration throughout life (Fig. 1B) . Morphological signs of degeneration such as reduced or absent rhabdomeres are observed by day 14 (Supplementary Material, Fig. S2A ). This phenotype is 
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highly penetrant, because each ommatidium is affected (Fig. 1D ). Like vertebrate Rho P23H , Rh1 P37H induces a dominant phenotype, as flies carry both wild-type and mutant genes. Rh1
WT transgenic photoreceptors, in contrast, display normal morphology at day 21 (Fig. 1F) .
Rho P23H -induced retinal degeneration is light-sensitive (17 -20) . Similarly, Rh1
P37H flies reared in the dark do not display a degenerative phenotype, even after 35 days of post-eclosion (Supplementary Material, Fig. S2B ). Furthermore, Rh1 P37H -expressing photoreceptors ( Fig. 1G and I-K) were kept under constant light illumination during 24 h and subsequently analyzed, already present degenerative signs, such as involution of microvillar rhabdomere membranes (see arrows in Fig. 1I ). Degenerating photoreceptor cytoplasm also contains a large number of lysosomes (see asterisks in Fig. 1G and J-K) and vacuoles (see 'V' in Fig. 1J and K) , as found by electron microscopy. Such degenerative signs are not observed in control, Rh1
WT -expressing, photoreceptors (Fig. 1H) . Therefore, the fly Rh1
P37H
-induced dominant retinal degeneration is age-and light-dependent.
Rh1
P37H induces progressive blindness Rho P23H -induced photoreceptor degeneration is associated with progressive blindness (6, 15, 16, 21 ) and therefore we analyzed the visual activity of Rh1 P37H flies at different ages.
Behavioral assay Wild-type flies are attracted by light, a phenotype that is abolished in blind strains (22) . We therefore assayed Rh1 P37H flies for fast phototaxis, a behavioral assay measuring the visual activity of a fly population (23) . In each test, flies are submitted to a sequence of five light stimuli in a countercurrent apparatus ( Fig. 2A) . Flies walking toward light are separated from those that do not, so that after the assay, the fly population is fractionated into six tubes for visual activity. Positive phototactic flies respond to light and reach the last tubes, whereas nonphototactic flies do not respond to light and stay in the first tubes. Flies with reduced visual activity end are distributed in the intermediate tubes.
We performed the phototaxis assay at days 1, 7 and 14 on wild-type flies and on Rh1 P37H or Rh1 WT transgenic flies ( Fig. 2B -D) . Wild-type and Rh1
WT flies show positive phototaxis, both at days 1 and 14, indicating that the Rh1 WT transgene does not modify fly vision throughout life (compare black and purple columns in Fig. 2B and C) . In contrast, Rh1 P37H flies are normal at day 1 (orange columns in Fig. 2B ), but display strongly reduced phototaxis at day 14, as shown by the large proportion of flies in the first two tubes (Fig. 2C) .
A quantitative evaluation of the phototactic behavior is represented by the phototactic score (PS) (24) , a parameter taking into account the total number of flies and the number of times flies have walked toward light, following a weighted average (see Fig. 2 ). Theoretically, for phototactic positive and non-phototactic flies, PS corresponds to 6 and 1, respectively. Experimentally, day 14 wild-type and Rh1-null (I17 ) flies display a PS of 5.1 and 1.1, respectively (light grey column in Fig. 2D and data Fig. 2D ). Thus, Rh1
P37H eye morphology correlates with visual behavior. Moreover, fast phototaxis provides a noninvasive, functional assay that detects progressive blindness well before morphological defects become manifest.
Electrophysiological assay Phototactic behavior integrates parameters as diverse as locomotion, photoreceptor stimulation, phototransduction, synaptic transmission to secondorder neurons and integration into the fly brain. To corroborate phototaxis data, we performed a direct measurement of visual activity by analyzing the electroretinogram (ERG). Fly ERG displays photoreceptor depolarization (Plateau), which corresponds to phototransduction cascade activation, and transient spikes following initiation and cessation of the light stimulus (ON and OFF), which results from synaptic activity ( Fig. 2E) (25) . This method allows for scoring of aged animals, which is not possible with the fast phototaxis assay, because locomotion decreases with age.
To accumulate further evidence of progressive blindness, we measured ERGs at different ages (days 1 -56) in flies of the following genotypes: wild-type, Rh1 P37H , Rh1 WT and Rh1-null (Fig. 2F ). Rh1-null flies, which lack R1 -R6 activity (12), provide a negative control and show reduced ERG resulting from R7 and R8 ( Fig. 2E) (26) . Rh1 P37H flies display ERG amplitude similar to that of Rh1 WT and WT flies at day 1 ( Fig. 2E) , confirming phototaxis data. With time, however, the Plateau amplitude of Rh1 P37H flies gradually decreases compared with that of positive controls and by day 56, it reaches that of blind Rh1-null flies (Fig. 2F) . Altogether, behavioral and electrophysiological data allow us to correlate morphological photoreceptor degeneration with progressive blindness.
P37H activates the visual signaling pathway
One major and still open question concerning the Rho P23H -induced degeneration is whether the mutant protein is able to transduce the light signal correctly. To analyze the activity of Rh1 P37H , we performed ERG in Rh1-null flies carrying the mutant or the wild-type transgene. Wild-type (WT) and Rh1-null flies were used as positive and negative controls, respectively. The Plateau as well as the ON and OFF profiles indicate that both transgenes rescue the ERG phenotype of Rh1-null flies at day 1 ( Fig. 3A and B ). When compared with WT and Rh1
WT flies ERG, however, Rh1 P37H flies display significant reduced ERG amplitude ( Fig. 3A and B) . This is not due to altered photoreceptor morphology (compare parts D and E with F and G of Fig. 3 Altogether, these data demonstrate that Rh1 P37H is able to transduce the light stimulus and that Rh1 P37H does not represent a null (complete loss of function) or a constitutively active (hypermorph) mutation. Finally, increasing the expression of the mutant protein does not improve the ERG amplitude ( Fig. 3C) , as revealed by using two copies of the mutant transgene. Thus, Rh1
P37H is not a hypomorph mutation (partial loss of function decreasing protein activity or expression).
Rh1 hsv-P37H displays partial mislocalization in the fly eye
The localization of the vertebrate mutant protein is matter of debate, because a large number of studies in cell cultures , whereas studies in vivo using transgenic animal models argue for Rho P23H proper localization to photoreceptor outer-segments (7,27 -32) . We therefore asked whether the degenerative phenotype is due to Rh1 P37H misexpression/ mislocalization. To specifically identify the mutant protein, we performed the analysis in flies lacking endogenous Rhodopsin by crossing Rh1 P37H or Rh1 WT transgenic flies with Rh1-null animals (referred to as Rh1
P37H
; Rh1-null and Rh1
WT ; Rh1-null, respectively). The amount of Rh1 expressed by Rh1 P37H ; Rh1-null and Rh1 WT ; Rh1-null flies is comparable, corresponding, respectively, to 53 and 52% of the Rh1 protein expressed in a wild-type strain, as quantified by densitometry (Fig. 4B) .
Using anti-Rh1 immunolabeling in adult eyes, we found that Rhodopsin proteins colocalize with the rhabdomeric marker phalloidin, showing that Rh1 P37H and Rh1 WT are correctly targeted to R1 -R6 apical microvilli ( Fig. 4C and  D) , and are also expressed at proper developmental stage (70% of pupal life) (data not shown).
In conclusion, Rhodopsin labeling shows the same developmental profile, cell-specificity and subcellular localization for Rh1 P37H and WT Rh1, consistent with the observation that Rh1 P37H activates the phototransduction pathway. One important question is to assess Rh1 P37H subcellular localization in a more physiopathologic context, namely in the presence of wild-type Rh1, as it is the case in ADRP patients. Indeed, it is interesting to check whether both proteins were colocalized at the subcellular level, under degenerating conditions.
For this purpose, we generated a transgenic line that expresses an Rh1 P37H protein tagged by hsv-epitope, under Human
the control of rh1 promoter (Rh1 hsv-P37H ). Hsv-epitope in fusion with C-terminus does not modify Rh1 properties (33) . Moreover, similar to Rh1 P37H flies, Rh1 hsv-P37H flies display reduced PS at day 7 that reflects photoreceptor degeneration, which is in contrast to Rh1 hsv-WT -expressing flies (data not shown). This tool allows us to specifically follow the behavior of the mutant protein in a genetic context that most faithfully reproduces that of patients affected by ADRP i.e., in presence of the endogenous wild-type Rhodopsin.
Rh1 hsv-P37H and control Rh1 hsv-WT flies were analyzed to compare subcellular localization of hsv-tagged Rhodopsins. Interestingly, anti-hsv labeling localizes to rhabdomeres in Rh1 hsv-WT flies (Fig. 4F ) (33) , and also to both rhabdomeres (inset) and cytoplasm (arrows) in Rh1 hsv-P37H flies (Fig. 4E ). This reveals a dual Rh1 hsv-P37H localization that is not detectable with anti-Rhodopsin-1 4C5 monoclonal antibody, as the latter labels only rhabdomeres (data not shown). Moreover, immunogold labelings analyzed by electron microscopy also show Rh1 hsv-P37H , but not Rh1 hsv-WT , localization to the ER (arrows, compare parts G and H of Fig. 4) . Thus, Rh1
hsv-P37H localizes both to rhabdomeres and ER, regardless of the presence of endogenous Rh1 (both in Rh1
WT and Rh1 null background) (data not shown). Finally, we used a polyclonal anti-Rh1 antibody as a third method to reveal Rhodopsin (34) and formally demonstrated that mutant protein (with or without hsv tag) is localized both in rhabdomeres and cytoplasm, whereas wild-type protein only localizes at rhabdomeres (Fig. 4I and J and data not shown).
The hsv tool also allowed us to ask another important question concerning the possibility that the presence of mutant Rhodopsin affects the subcellular localization of wild-type endogenous Rh1. For this, we performed anti-hsv labeling on eye sections that express both Rh1 hsv-WT and Rh1 P37H transgenes in Rh1 null background. The fact that only wild-type protein is detected in rhabdomeres (Fig. 4K) clearly demonstrates that Rh1 P37H mislocalization does not affect that of wild-type Rhodopsin.
Protein accumulation in ER has been shown to activate pathways that lead to phosphorylation and thereby activation of stress-specific MAPKs named p38 and JNK (35) 
Rh1-WT). In contrast with Rh1
wt restricted in rhadomeres (J), anti-Rh1 polyclonal antibody confirms Rh1 P37H dual localization in rhabdomeres and cytoplasm (arrows I). 1-7 indicate R1-R7 photoreceptors, respectively. Scale bars: 2 mm (A, C-E, I-K); 0.5 mm (G, H).
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MAPKs in western blot assay from Rh1 hsv-P37H -and Rh1 hsv-WT -expressing head extracts. The signal obtained using antibody against the phosphorylated form of p38 (activated p38) is stronger in Rh1 hsv-P37H -expressing head extracts (day 7 or 14) than in Rh1 hsv-WT head extracts (Fig. 5A) . We obtained the same result by using Rh1 P37H flies (data not shown). We also observed that phosphorylation of JNK protein, another stress-induced MAPK, is also increased in the mutant, albeit at lower level, as compared to p38 (Fig. 5B) .
This clearly shows that Rh1 P37H expression leads to stressinduced MAPK activation. Moreover, by looking at the subcellular level, we could assign this activation to the degenerating cells, as we specifically detected Phospho-p38 translocation in mutant photoreceptor nuclei (Fig. 5C and D) .
Blocking apoptosis rescues the Rh1
P37H phenotype
Previous studies realized on vertebrate models suggest that Rho P23H triggers an apoptotic pathway (19, 36, 37) . To characterize the mechanisms of photoreceptor loss, we analyzed aged Rh1 P37H ommatidia by electron microscopy and observed several apoptotic features such as dense nuclei (compare Fig. 6E -G) , devolution of rhabdomeric membranes and loss of sub-rhabdomeric structures (compare Fig. 6C , D and H and see Fig. 1I ). We also found that p35 anti-apoptotic protein (38) fully prevents the light-induced photoreceptor loss (Fig. 6B) . Furthermore, p35 rescues rhabdomere and nucleus ultrastructure defects ( Fig. 6D and F) . Most importantly, p35 rescues the phototactic behavior (Fig. 6I) . Indeed, Rh1 P37H flies' PS at day 14 corresponds to 3.6, whereas that of Rh1 P37H flies expressing p35 corresponds to 5.3 (Fig. 6I) , which is very similar to the score of phototaxis-positive flies (see Fig. 2 ). Finally, p35 expression also partially rescues the ERG phenotype (Plateau amplitude: Rh1 P37H ¼ 25.84 mV; Rh1 P37H þ p35 ¼ 28.04 mV) (Fig. 6J ). We therefore conclude that Rh1 P37H -induced degenerative mechanisms converge onto an apoptotic pathway and that it is possible to prevent photoreceptor loss of function by blocking such pathway.
DISCUSSION
We here present a fly transgenic model for Rho P23H -induced RP that allows us to characterize the pathogenic mechanisms by functional and morphological assays. We show that mutant Rhodopsin is partially active and interferes with the phototransduction pathway. We also show that most of the mutant Rhodopsin is trapped in ER, which activates stressMAPKs, and that the degeneration phenotype is rescued by p35 anti-apoptotic factor.
The Rh1
P37H fly: a model for Rho P23H -induced degeneration
Rh1
P37H induces age-dependent and progressive phenotypes. For patients and vertebrate models, young transgenic flies carrying mutant Rhodopsin display wild-type phototactic behavior, electrophysiological responses and photoreceptor morphology. Rh1 P37H flies show first signs of blindness at day 7 post-eclosion (Fig. 2D) . Moreover, in Rho P23H rodents (6, 7, 16, 39) , Rh1 P37H flies show progressive functional (phototaxis and ERG) and morphological defects (Fig. 2D , data not shown, Supplementary Material, Fig. 2A) . Finally, Rh1
P37H -induced degeneration is dominant and light-dependent, as seen in the vertebrate models (17 -20) .
These data clearly show that Rh1 P37H transgenic flies faithfully reproduce the pathological events occurring in ADRP patients that carry the Rho P23H mutation. This allows us to use Drosophila as a novel animal model to study the Rho P23H -induced RP and to characterize the molecular mechanisms triggering degeneration.
P37H responds to light
One of the most challenging questions is to determine the molecular pathways leading to photoreceptor degeneration. Depending on the rhodopsin mutation, distinct pathogenic mechanisms have been proposed, affecting protein activity or localization. Our data allow us to draw first conclusions on the cause of Rh1 P37H -induced defects. 
WT (D) longitudinal sections (day 7) immunolabeled with anti-Phosphop38 (green). Phalloidin labels rhabdomeric F-Actin in red and DAPI labels photoreceptor nuclei in blue, surrounded by dotted lines (n ), arrows show activated p38 translocated into nucleus. Scale bars: 2 mm.
A frequently described cause of retinal degeneration involves Rhodopsin dysfunction: rhodopsin mutations failing to activate phototransduction (40) and mutations inducing lightindependent constitutive activity lead to retinal degeneration in flies, transgenic mice and patients (41, 42) . Our electrophysiological data show for the first time that Rh1 P37H is able to trigger photoreceptor depolarization and synaptic activity. This is the first evidence that the mutant protein is active, as the very early onset of degeneration of Rho P23H transgenic mice lacking endogenous Rhodopsin prevents from evaluating the intrinsic activity of Rho P23H (43) . Moreover, although Rh1 P37H displays a reduced ERG, it does not constitute a hypomorph mutation, as two copies of the mutant transgene in a genetic rhodopsin null background neither restore nor improve partially ERG wild-type amplitude. In addition, the fact that degeneration is not observed in flies kept in the dark speaks against Rh1 P37H being a constitutively active mutation (Supplementary Material, Fig. S2B ).
Our genetic data also allow us to exclude the possibility that Rh1 P37H -induced degeneration is due to Rhodopsin excess, as transgenic Rh1
WT expressed at comparable level as Rh1
P37H
does not induce degeneration. Therefore, Rh1 P37H does not constitute a hypermorph mutation, which is consistent with the observation that expressing two doses of Rh1
WT does not impair visual behavior (Supplementary Material, Table S1 ). By comparison, vertebrate Rho WT does trigger photoreceptor degeneration but only when overexpressed at extremely high levels (7). Finally, and more interestingly, performing the same dosage experiment with Rh1 P37H further aggravates the mutant phenotype, as flies carrying one dose of Rh1 P37H in a wild-type rhodopsin background see better than those carrying two doses of the same transgene (Supplementary Material, Table S1 ).
Altogether, the genetic approach allows us to demonstrate for the first time that Rh1 P37H acts neither as a partial or complete loss of function (null/hypomorph) nor as a hypermorph or constitutively active mutation. Rather, Rh1
P37H acts an antimorph, due to the cytotoxic effects induced by mislocalized Rh1 P37H molecules (see subsequently). Thus, mutant, mislocalized, Rhodopsin indirectly interferes with the phototransduction cascade.
Rh1
P37H dual localization A second cause of photoreceptor-dominant degeneration is abnormal Rhodopsin trafficking (44) . Indeed, a large number of dominant mutations throughout Rh1 cause protein sequestration in ER in flies (45, 46) . Concerning Rho
P23H
, subcellular localization of the mutant protein is still under debate. Rho P23H mislocalization has been observed in vertebrate transfected cells (27 -31) , whereas in transgenic animals it is properly targeted to photoreceptor outer-segments (7, 28, 32) . The use of transgenic wild-type and mutant-tagged Rhodopsins has made it possible to unambiguously address the issue of protein localization in vivo. Indeed, our immunolabeling data illustrate both localizations for mutant Rhodopsin. On one hand, we detect Rh1 P37H labeling (monoclonal anti-Rh1) in rhabdomeres, even in a Rhodopsin wild-type background, which mimics the genetic context of RP patients (Supplementary Material, Fig. S2E  and F) . On the other hand, we also show Rh1 hsv-P37H labeling in cytoplasm by using both a polyclonal anti-Rh1 antibody (34) (Fig. 4I arrows) and an anti-hsv antibody in tagged transgenic lines (Fig. 4E) indicating that the epitope recognized by the 
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Rh1 monoclonal antibody is masked, either by misfolding or because altered protein interaction, as it has been described for the inactive form of Rh1 bound to Arrestin-2 (34) . Most of the Rhodopsin-dominant mutations described in Drosophila, acting on mutant protein maturation trough ER, also interfere with the wild-type Rhodopsin transport (45, 47) . In the case of Rh1 P37H , however, mutant Rhodopsin sequestration in ER does not interfere with the Rh1 hsv-WT transport to rhabdomeres.
Finally, in contrast to many dominant rhodopsin mutations in Drosophila causing ER membrane accumulation (45, 46) , Rh1 P37H flies show normal ER ultrastructure (Supplementary Material, Fig. S2C) , similar to what observed in Rho P23H mice (7, 28) . Our data favor the hypothesis that Rhodopsin transport is partially impaired allowing a small proportion of Rh1 P37H to properly localize to rhabdomeres, where it is functional.
Protein accumulation in ER has been described to trigger apoptosis in some neurodegenerative processes such as Alzheimer's disease, through the so-called ER stress pathway (48) . To respond to this ER stress and to get rid of protein excess, the unfolded protein response (UPR) signaling network is subsequently activated, which in turn finally leads to the activation of stress-MAPKs p38 and JNK (35) . We have shown that P37H mutation triggers Rh1 sequestration in ER and triggers p38 and JNK activation, which is specific to photoreceptors.
Rh1
P37H -induced degenerative mechanism leads to apoptosis
The fact that Rh1 P37H photoreceptors undergo apoptosis and this phenotype is fully rescued by expressing p35 anti-apoptotic factor strongly suggest that Rh1 P37H activation ultimately leads to caspase activation (49) . Several mutations altering the phototransduction cascade (Rh1 C200Y , rdgC, arr2 or norpA ) inducing age-and light-dependent degeneration in flies are also fully (50 -53) or partially (54) prevented by p35 expression (50 -54) . Most importantly, the observation that Rh1 P37H -induced phenotype is morphologically and functionally rescued by p35 demonstrates a therapeutic effect of late-stage inhibition of apoptosis in adult flies. As apoptosis has been described in a variety of vertebrate models for retinal degeneration (55) , the present data confirm the interference of apoptotic pathways as a promising therapeutic tool for human retinal dystrophies (56) .
The activation of the UPR on ER stress has been described to trigger apoptosis, when such a pathway is not sufficient to get rid of the accumulated protein in ER (35) . In view of our data, we propose that Rh1 P37H accumulation in the ER causes apoptosis trough activation of a stress pathway that leads to p38 and JNK phosphorylation. In the future, it will be interesting to discuss the pathway leading to stress-MAPKs activation and to determine whether UPR is involved in it.
In conclusion, our data are emblematic of the conservation of the visual system between invertebrates and vertebrates. They validate the fly transgenic model to study the photoreceptor degeneration and shed light onto the pathogenic pathway associated with the Rho P23H -induced RP. Use of flies makes it possible to perform genetic screens aiming at finding genes that modify Rh1 P37H photoreceptor degeneration. This represents a promising avenue to identify viability factors that may be used for therapeutic purposes. (33) . p35 rescue experiments are performed using w,p(ry þ rh1-Gal4) and p(w
MATERIALS AND METHODS
Transgenesis and
) flies (Bloomington stock center). Drosophila are raised on corn-medium, under day/ nightlight conditions that correspond to 12 h dark/light at 258C. Constant illumination conditions are obtained by using two photosynthetic fluorescent tubes (in total 350 cd/m 2 ) at 258C. In all illumination conditions, pupae were reared in 12 h dark/light cycles.
Western blotting analysis
Heads are mashed in lysis buffer (20 mM phosphate buffer of pH 7, 1% SDS). One hundred and fifty micrograms of protein extracts are loaded on a 10% SDS -PAGE and transferred on nylon membrane. Anti-Rh1 4C5 antibody is used at 1/100 (DSHB), rabbit anti-Phospho-p38 and anti Phospho-JNK at 1/700 (Cell signaling) and b-tubulin antibody is used for normalization (0.25 mg/ml) (Chemicon).
Histology and immunohistochemistry
For histology, heads are dissected and fixed 24 h in 2.5% glutaraldehyde, 4% paraformaldehyde, Na phosphate buffer (0.1 M, pH 7.4), post-fixed in 1% osmium tetroxide in 0.1 M Na phosphate buffer, dehydrated in graduated ethanol series and propylene oxide. Heads are embedded in epon. Semi-thin sections of 2 mm are stained with toluidin blue, 70 nm ultra-thin sections are contrasted with uranyl acetate and lead citrate, and analyzed using Philips EM208 electron microscope.
For fluorescent immunolabeling, heads are dissected and fixed 20 min in 4% formaldehyde, incubated in 10 and 25% sucrose 2 and 6 h, respectively, and embedded in cryomedium. Cryosections of 20 mm are fixed for 10 min (4% formaldehyde), permeated with 0.1% Triton X-100 PBS (PBST) and blocked 1 h with 5% goat serum in PBST. Primary and secondary antibodies are diluted in blocking solution and incubated overnight at 48C and 1 h at room temperature, 2 ) is chosen as the minimal intensity that consistently produces maximal ERG Plateaus. Signals are filtered at 2 kHz and digitized at 10 kHz, using a MultiClamp 700 A amplifier, Digidata 1322 A interface and pClamp-8 software (Axon Instruments). Flash intensity and duration are controlled through pClamp and Digidata.
